06:45 – 08:45
Lobby Entrance
- (outside)
10th Annual CFID Bug Run
07:00 – 13:30
North Tower
- Parksville
Escape Room
07:00 – 14:00
North Tower
- Junior Ballroom Foyer
Conference Registration
07:00 – 14:00
North Tower
- Junior Ballroom Foyer
Internet Café
07:00 – 16:00
North Tower (lower lobby)
- Gulf Island A
Speaker Ready Room
07:00 – 18:00
B Tower
- Beluga
Sponsor Lounge – BD
07:00 – 08:45
North Tower (4th floor)
- Port McNeill
CCM AGM
07:00 – 08:45
B Tower (3rd Floor)
- Orca
AMMI Canada Phage Working Group Steering Committee Meeting
07:00 – 08:45
South Tower (4th floor)
- Granville
AMMI Canada Paediatric Committee and PICNIC Meeting
09:00 – 11:00
North Tower
- Grand Ballroom BC
Plenary
What’s Hot in Paediatric Infectious Disease/Medical Microbiology/Antimicrobial Stewardship/IPAC/Adult Infectious Disease
Welcome and Introductions
MODERATORS:
Earl Rubin (QC)
Larissa Matukas (ON)
What's Hot in Paediatric Infectious Disease
SPEAKER:
Kirk Leifso (ON)
At the end of this session, participants should be able to:
- Describe recent findings that impact the practice of paediatric infectious disease
What's Hot in Medical Microbiology
SPEAKER:
Marthe Charles (BC)
At the end of this session, participants should be able to:
- Describe recent findings that impact the practice of medical microbiology
What's Hot in Antimicrobial Stewardship
SPEAKER:
Nicole Le Saux (ON)
At the end of this session, participants should be able to:
- Describe recent findings that impact the practice of antimicrobial stewardship
What's Hot in Infection Prevention and Control
SPEAKER:
Jennie Johnstone (ON)
At the end of this session, participants should be able to:
- Describe recent findings that impact the practice of infection prevention and control
What's Hot in Adult Infectious Disease
SPEAKER:
Christian Lavallée (QC)
At the end of this session, participants should be able to:
- Describe recent findings that impact the practice of adult infectious disease
11:00 – 14:00
North Tower
- Pavilion Ballroom and Junior Ballroom
Exhibit Hall Open / Poster Viewing
11:00 – 11:30
North Tower
- Pavilion Ballroom and Junior Ballroom
Break
11:30 – 12:30
North Tower
- Grand Ballroom A
Adult-designed Vaccines – A Paradigm Shift Long Overdue
(co-developed learning activity, pre-registration required to maximum of 150 participants)
MODERATOR:
Vanessa Meier-Stephenson (AB)
SPEAKERS:
Brian Ward (QC)
Greg Tyrrell (AB)
At the end of this session, participants should be able to:
- Describe the paradigm shift to now having options of adult-designed vaccines
- Summarize the available adult-designed vaccines
- Discuss NACI’s recommendations regarding the use of adult-designed vaccines
This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and Merck Canada and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.
11:30 – 12:30
North Tower
- Grand Ballroom D
HPV Primary Screening Implementation in British Columbia: From the Clinical Perspective and Laboratory Perspective
(co-developed learning activity, pre-registration required to maximum of 150 participants)
MODERATOR:
Susan Poutanen (ON)
SPEAKERS:
Lily Proctor (BC)
Mel Krajden (BC)
At the end of this session, participants should be able to:
- Describe different pragmatic approaches to taking action regarding cervical cancer prevention
- Discuss British Columbia’s approach as a case example
This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and Roche and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.
12:30 – 13:30
North Tower
- Pavilion Ballroom and Junior Ballroom
Lunch in Exhibit Hall
12:45 – 13:45
North Tower
- Pavilion Ballroom
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Rapid Fire Session A Poster Presenters at Posters to Answer Questions
| RFA01 (#27) | Increased rates of laboratory confirmed cases of syphilis in Western Canadian vs Eastern Canadian blood donors: 2022-2023 Presenting: Steven Drews |
| RFA02 (#88) | Sample processing methodology alters observed diversity in metagenomic and metatranscriptomic microbiome profiles from human stool Presenting: Molly Pratt |
| RFA03 (#174) | Optimizing methods for the genomic surveillance of viral pathogens in wastewater Presenting: Ian Restall |
| RFA04 (#191) | Molecular epidemiology of rotavirus strains in Quebec from January to June 2023 Presenting: Maude Paquette |
| RFA05 (#68) | Prevalence of antibodies to human t-cell lymphotropic virus-1/2 in Canada over thirty-three years of monitoring in blood donors Presenting: Steven Drews |
| RFA06 (#141) | Assessing the potential for specimen pooling to streamline nosocomial surveillance of methicillin resistant Staphylococcus aureus (MRSA) Presenting: Mohammed Alqatani |
| RFA07 (#182) | Applying whole genome approaches to identify and resolve influenza A outbreaks in humans and animals Presenting: Shannon Russell |
| RFA08 (#183) | Epidemiology and clinical characteristics of severe malaria in Canada, 2014-2022 Presenting: Mireille Desroches |
| RFA09 (#295) | Emergence of a novel FRI-type carbapenemase (blaFRI -12) in Enterobacter cloacae complex located on a novel IncR plasmid isolated in Canada Presenting: Laura Mataseje |
| RFA10 (#370) | Association between use of a voluntary isolation centre and transmission of SARS – CoV -2: a matched cohort study of households Presenting: Kevin Brown |
| RFA11 (#309) | A Comprehensive Risk Assessment Algorithm -guided SARS CoV -2 Vaccine Composition Strategy Presenting: Victor Kramer |
| RFA12 (#312) | FluViewer: an automated bioinformatic pipeline for generating influenza A virus consensus genomes regardless of viral subtype or host Presenting: Kevin Kuchinski |
12:45 – 13:45
North Tower
- Pavilion Ballroom
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Rapid Fire Session B Poster Presenters at Posters to Answer Questions
| RFB01 (#69) | Use of Dalbavancin in treatment of Acute Bacterial Skin and Skin Structure Infections: Prospective Case Series from a Canadian Perspective Presenting: Wayne Leung |
| RFB02 (#258) | Verification of the Aptima Bacterial Vaginosis (BV) and Candida/Trichomonas (CV/TV) assays on the Hologic Panther Presenting: Emily MacAdam |
| RFB03 (#41) | Clinical validation of an optimized and automated agnostic diagnostic assay for detection of respiratory viruses Presenting: Nick Gauthier |
| RFB04 (#58) | Multivariate analysis of risk factors predicting 28 -day mortality among adult patients presenting with bacteremia in the emergency department Presenting: Noémie Laurier |
| RFB05 (#75) | Infectious diseases consultation is associated with reduced mortality in hospitalized patients with Gram-negative bloodstream infection: a population-wide cohort study Presenting: Sean Ong |
| RFB06 (#198) | HCV Reinfection Among People Who Use Drugs (PWUD) treated for HCV Infection: A Long -Term View Presenting: Saina Beitari |
| RFB07 (#213) | Impact of antimicrobial copper surfaces on microbial load and healthcare-acquired infection rates in long -term care settings: a comparative study in Canada Presenting: Hasan Hamze |
| RFB08 (#133) | MRSA isolates resistant to trimethoprim-sulfamethoxazole by VITEK2 and BD Phoenix antibiotic susceptibility testing systems but susceptible by Etest and disk diffusion harbour a resistant subpopulation Presenting: Farhan Khan |
| RFB09 (#270) | Validation of Python scripts vs. Excel for cleaning, analysis, and visualization of surveillance and methods evaluation data Presenting: Yerin Lee |
| RFB10 (#287) | Impacts of SARS -CoV -2 and non-pharmaceutical interventions on the seasonal incidence of hospitalizations for acute respiratory diseases among children Presenting: Christina Lukac |
| RFB11 (#306) | Clinical and public health management of bacterial gastroenteritis in the world of culture -independent diagnostic testing (CIDT): A pilot study to evaluate kinetics of bacterial shedding by culture and CIDT Presenting: Nathan McCartney |
| RFB12 (#324) | SARS -CoV -2 seropositivity in Alberta: the Omicron era Presenting: Sa’adiya Umar |
12:45 – 13:45
North Tower
- Junior Ballroom
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Poster Presenters at Posters to Answer Questions
| FP001 (#33) | A case of severe native valve infective endocarditis (IE) caused by Streptobacillus moniliformis (Rat-bite fever) Presenting: Chu (Sandy) Wang |
| FP002 (#49) | Polymicrobial Streptococcus mitis and Vagococcus fluvialis Infective Endocarditis Presenting: Alexander Pupek |
| FP003 (#87) | Partially-treated Actinomyces orisnative mitral valve endocarditis masquerading as subacute, relapsing fevers over a 6-month period Presenting: Jason Zou |
| FP004 (#106) | Bacteremia secondary to a phenotypically susceptible blaCTX-M27positive Escherichia coli Presenting: Geneviève Amaral |
| FP005 (#120) | Presumed travel-related pulmonary cystic echinococcosis in a child: Case report Presenting: Heba Hamed |
| FP006 (#129) | Cutaneous Alternariosis in Acute Lymphocytic Leukemia Presenting: Reza Rahimi Shahmirzadi |
| FP007 (#145) | Snowshoe Hare Virus meningoencephalitis in a child Presenting: Alison Lopez |
| FP008 (#158) | Malaria in Canada? A case of Babesia microti infection in a returning traveller from Nova Scotia Presenting: Jamil Kanji |
| FP009 (#166) | Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) treatment for multidrug-resistant extrapulmonary tuberculosis (MDR-EPTB) in Canada: a case report Presenting: Jollee Fung |
| FP010 (#196) | First case report of disseminated gonococcal arthritis in a Canadian province Presenting: Nessika Karsenti |
| FP011 (#197) | Navigating the challenges: Managing mold, mycobacterial, and viral infections in a hematopoietic stem cell transplant recipient Presenting: Wayne Leung |
| FP012 (#218) | Candida blankii : The difficult capture of a fungus with pathogenic potential Presenting: Arjun Sharma |
| FP013 (#245) | Unmasking complexity: Navigating the diagnostic challenge of a false-positive cryptococcal antigen in chronic meningitis with suspected indolent CNS B-cell lymphoproliferative neoplasm Presenting: Melissa Fowler |
| FP014 (#246) | Less is more? Two cases of cryptococcosis treated using single-dose liposomal amphotericin B as part of induction therapy in solid organ transplant recipients Presenting: Carson Lo |
| FP015 (#252) | A palatable diagnosis: Disseminated Blastomycoses with Mucocutaneous involvement Presenting: Helen Genis |
| FP016 (#255) | Bilateral thigh abscesses caused by Mycobacterium chelonae in the context of patient-administered testosterone injections Presenting: Lili Ataie |
| FP017 (#265) | Delayed presentation of rhinoscleroma with laryngeal involvement in a patient who immigrated to Canada from El Salvador 25 years prior to diagnosis Presenting: Lise Bondy |
| FP018 (#266) | Invasive Pulmonary Irpex lacteus infection in an immunocompromised patient with Myelodysplastic Syndrome Presenting: Elizabeth Simms |
| FP019 (#277) | Prosthetic joint infection with carbapenem-resistant Acinetobacter baumannii treated with colistin and sulbactam-durlobactam: A case report and review of the literature Presenting: Roy Hutchings |
| FP020 (#278) | A case report of long-standing Profound Neutropenia with uncertain etiology and concomitant Cutaneous Fungal Infection Presenting: Esraa Babaeer |
| FP021 (#281) | Leveraging additive antibiotic effects: management of an extensively drug resistant Pseudomonas aeruginosa bloodstream infection Presenting: Andrew Purssell |
| FP022 (#340) | Rituximab friend or foe?: PML in a non-HIV patient with non-Hodgkin lymphoma post rituximab and autologous stem cell transplant treatment Presenting: Tanna Lauriente |
| FP023 (#353) | Chronic schistosomiasis in a paediatric patient following allogeneic haematopoietic stem cell transplantation: A case report and review of the literature Presenting: Stephanie Zahradnik |
| FP024 (#359) | Two simultaneous carbapenemase-producing Enterobacterales (CPE) outbreaks in a Canadian tertiary care centre: Highlighting gaps in CPE screening and outbreak management Presenting: Matthew Driedger |
| FP025 (#361) | Blastomyces dermatitidis mastoiditis and venous sinus thrombosis in an adolescent: an uncommon pairing of common diseases Presenting: Matthew Kochan |
| FP026 (#262) | When malaria gets mixed: Complications in Plasmodium species detection with multiplexed PCR Presenting: Kelly Lozinski |
14:00 – 16:00
North Tower
- Grand Ballroom Foyer
Conference Registration
14:00 – 15:00
North Tower
- Grand Ballroom BC
Vaccines for Those with Compromised Immune Function Due to Aging and Comorbidities
(co-developed learning activity)
MODERATOR:
Peter Pieroni (MB)
SPEAKER:
Mark Loeb (ON)
At the end of this session, participants should be able to:
- Explain how aging and comorbidities affect immune function and increase susceptibility to severe infections
- Describe current technologies used to optimize vaccine efficacy amongst older adults and those with comorbidities
- Discuss the role of vaccines in reducing risk of severe infections in older adults and those with comorbidities
This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and GSK and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.
15:00 – 15:10
North Tower
- Grand Ballroom Foyer
Break
15:10 – 16:10
North Tower
- Grand Ballroom A
Masterclass E
Travel Bug? We've Got a Vaccine for That!
(pre-registration required to maximum of 150 participants)
MODERATOR:
Farhan Khan (NB)
SPEAKERS:
Isaac Bogoch (ON)
Michael Libman (QC)
At the end of this session, participants should be able to:
- Describe new and emerging vaccines for tropical infectious diseases
- Describe recommended pre-travel vaccines routinely suggested for Canadians
- Summarize relevant updates in travel and tropical medicine for Canadian Infectious Diseases providers
15:10 – 16:10
North Tower
- Grand Ballroom D
Masterclass B
Congenital Infections with a Focus on CMV and HSV
(pre-registration required to maximum of 150 participants)
MODERATOR:
Earl Rubin (QC)
SPEAKER:
David Kimberlin (AL, USA)
At the end of this session, participants should be able to:
- Summarize the epidemiology of common congenital infections
- Discuss presentations and management of common congenital infections
- Describe preventative measures to reduce the incidence of congenital infections
16:10 – 16:15
North Tower
- Grand Ballroom Foyer
Break
16:15 – 17:30
North Tower
- Grand Ballroom BC
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Case Reports Presentations and Closing Remarks
Moderators:
Susan Poutanen (ON)
Rob Kozak (ON)
| CR001 (#13) | Powassan virus encephalitis after tick bite in rural Manitoba Presenting: Nathan Smith |
| CR002 (#14) | Neck mass misdiagnosed as a possible malignancy: Tularemia, the ancient disease which remains unknown to the medical community and a high risk to laboratory personnel Presenting: Élodie Gemme |
| CR003 (#317) | Topical, oral, and bladder-instilled phage therapy treats E. coli cystitis: an open-label single patient Canadian clinical trial Presenting: Greg German |
| CR004 (#330) | Balamuthia mandrillaris : A locally acquired fatal case, possibly a first for Canada? Presenting: Clayton MacDonald |
| CR005 (#332) | Mediastinal necrotizing lymphadenitis Histoplasmosis in a 16 year old Crohn’s patient Presenting: Adiel Marom |
| Closing Remarks | Agatha Jassem (BC) Deb Yamamura (ON) |